Peina Du
Beijing Genomics Institute
11 Papers
4 Citations
Peina Du is an academic researcher from Beijing Genomics Institute. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 5, co-authored 7 publications. Previous affiliations of Peina Du include Shanghai Jiao Tong University.
Chat about Author
Papers
The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals.
Yanan Cao,Lin Li,Min Xu,Zhimin Feng,Xiaohui Sun,Jieli Lu,Yu Xu,Peina Du,Tiange Wang,Ruying Hu,Zhen Ye,Lixin Shi,Xulei Tang,Li Yan,Zhengnan Gao,Gang Chen,Yinfei Zhang,Lulu Chen,Guang Ning,Yufang Bi,Weiqing Wang +20 more
TL;DR: This study establishes a large-scale and deep resource for the genetics of East Asians and provides opportunities for novel genetic discoveries of metabolic characteristics and disorders.
Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer.
Zitong Zhao,Lin Li,Peina Du,Liying Ma,Weimin Zhang,Leilei Zheng,Bo Lan,Bailin Zhang,Fei Ma,Bo Xu,Qimin Zhan,Qimin Zhan,Yongmei Song +12 more
TL;DR: The findings suggest that miR-4306 acts as a tumor suppressor in TNBC and is a potential therapeutic target for TNBC treatment.
88
The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment
Weimin Zhang,Weimin Zhang,Ruoxi Hong,Lin Li,Lin Li,Yan Wang,Peina Du,Yunwei Ou,Zitong Zhao,Xuefeng Liu,Wenchang Xiao,Dezuo Dong,Qingnan Wu,Jie Chen,Yongmei Song,Qimin Zhan,Qimin Zhan +16 more
TL;DR: This study comprehensively characterized SCNAs in ESCC and highlighted the crucial role of miR-548k in promoting lymphatic metastasis, which might be employed as a new diagnostic and prognostic marker for ESCC.
The molecular landscape of synchronous colorectal cancer reveals genetic heterogeneity.
Xiangfeng Wang,Hu Fang,Yong Cheng,Lin Li,Xiaohui Sun,Tao Fu,Peide Huang,Anping Zhang,Zhimin Feng,Chunxue Li,Xuanlin Huang,Guangyan Li,Peina Du,Huanming Yang,Xiaodong Fang,Fan Li,Qiang Gao,Baohua Liu +17 more
TL;DR: The data show that the syCRCs within the same patient present great genetic heterogeneity, and they may be driven by distinct molecular events and develop independently, and the discrepancy of potential drug targets and mutation burden in lesions from one patient provides valuable information in clinical management for patients with syC RCs.
30
The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinoma
Xuesong Liu,Ruoxi Hong,Peina Du,Di Yang,Meibo He,Qingnan Wu,Lin Li,Yan Wang,Jie Chen,Qingjie Min,Jinting Li,Weimin Zhang,Qimin Zhan +12 more
TL;DR: A deep insight is provided into the metabolic landscape in ESCC, extending the understanding of the metabolic reconfiguration underlying the genomic basis of ESCC.
11